Sacrificing Our TODAY for the World's TOMORROW
FATA is "Federally Administered Tribal Area" of Pakistan; consisting of 7 Agencies and 6 F.Rs; with a 27000 Sq Km area and 4.5 m population.
MYTH: FATA is the HUB of militancy, terrorism and unrest in Afghanistan.
REALITY: FATA is the worst "VICTIM of Militancy”. Thousands of Civilians dead & injured; Hundreds of Schools destroyed; Thousands of homes raised to ground; 40% population displaced from homes.
Showing posts with label HealthDiseases. Show all posts
Showing posts with label HealthDiseases. Show all posts

Sunday, May 29, 2011

UNICEF discloses vaccine prices charged by Drugmakers for 1st time (Associated Press, 28 May 2011)

Courtesy: "Associated Press (AP)", 28 May 2011
UNICEF discloses vaccine prices for 1st time

UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
On Friday, UNICEF posted on its website the actual prices that it has paid individual drugmakers for 16 vaccines purchased over the last decade. It's a move that a few Western pharmaceutical companies don't support. Novartis AG and Merck & Co., which only sells one of its many children's vaccines to UNICEF, both declined to have their prices published.
UNICEF said it will continue to disclose pricing of future vaccine deals, with the hope that the transparency will push drugmakers to cut prices and thus allow the organization to vaccinate more children and save more lives.

Saturday, May 28, 2011

Euthanasia (Mercy Killing) & India: Supreme Court Verdict in Aruna Shanbaug case Revives Debate (IPS News, 27 May 2011)

Courtesy: "Inter Press Service (IPS)", 27 May 2011
Supreme Court Verdict Revives Euthanasia Debate
By Sujoy Dhar
MUMBAI, May 27, 2011 (IPS) - In a secluded hospital bed in this bustling Indian metropolis, a woman who has lain brain dead for 37 years after a brutal sexual assault is at the centre of a national debate on mercy killing.
India’s Supreme Court has ruled that Aruna Shanbaug should live, while at the same time supporting passive euthanasia - or the withholding of medical treatments that are keeping her alive.
The court’s decision to rule out euthanasia of any kind for Shanbaug gladdened her former colleagues - nurses at the King Edward Memorial (KEM) Hospital - who have taken care of her since the day in 1973 when she was sodomised and strangled with a dog chain by a hospital custodian whose advances she had spurned.

The costly war on cancer: New cancer drugs are technically impressive. But must they cost so much? (The Economist, 26 May 2011)

Courtesy: "The Economist", 26 May 2011
The costly war on cancer
New cancer drugs are technically impressive. But must they cost so much? CANCER is not one disease. It is many. Yet oncologists have long used the same blunt weapons to fight different types of cancer: cut the tumour out, zap it with radiation or blast it with chemotherapy that kills good cells as well as bad ones.
New cancer drugs are changing this. Scientists are now attacking specific mutations that drive specific forms of cancer. A breakthrough came more than a decade ago when Genentech, a Californian biotech firm, launched a drug that attacks breast-cancer cells with too much of a certain protein, HER2. In 2001 Novartis, a Swiss drugmaker, won approval for Gleevec, which treats chronic myeloid leukaemia by attacking another abnormal protein.

Vatican convenes AIDS experts amid condom flap (Associated Press, 27 May 2011)

Courtesy: "Associated Press (AP)", 27 May 2011
Vatican convenes AIDS experts amid condom flap

VATICAN CITY (AP) -- The Vatican on Friday welcomed AIDS experts from around the world for a two-day symposium on preventing HIV and caring for people with the virus, just months after the pope made international headlines with his groundbreaking comments about condoms and AIDS.
Organizers insist the meeting won't call into question traditional church teaching opposing artificial contraception. Yet Pope Benedict XVI's comments last year about condom use with prostitutes with HIV seem to have removed a certain Vatican taboo that had all but ruled out public discussion of whether condoms were even effective in reducing HIV transmission.

Thursday, May 26, 2011

Josh Winstead & Courtney Montgomery: Teen bond overcomese girl's heart transplant fear (Associated Press)

 Courtesy: "Associated Press (AP)", 23 May 2011
Teen bond overcomes girl's heart transplant fear

WASHINGTON (AP) -- Courtney Montgomery's heart was failing fast, but the 16-year-old furiously refused when her doctors, and her mother, urged a transplant.
Previous surgeries hadn't helped and the North Carolina girl didn't believe this scarier operation would either. It would take another teen who's thriving with a new heart to change her mind.
"I was like, `No, I don't want this. If I'm going to die, I'm going to die,'" Courtney recalls. "Now I look back, I realize I wasn't thinking the way I should have been."
Teenagers can add complex psychology to organ transplantation: Even though they're minors, they need to be on board with a transplant because it's up to them to take care of their new organ. Depression, anger and normal adolescent pangs - that tug-of-war with parents, trying to fit in - can interfere. It's not just a question of having the transplant, but how motivated they are to stick with anti-rejection treatment for years to come.

Wednesday, May 18, 2011

Measles Claims Many Lives in Congo as Public, Private Resources Stretched Thin (Inter Press Service, 18 May 2011)

Courtesy: "Inter Press Service (IOS)", 18 May 2011
Measles Claims Lives as Public, Private Resources Stretched Thin
By Emmanuel Chaco
KINSHASA, May 18, 2011 (IPS) - More than 3,000 cases of measles have been recorded in the past three months in two districts of Maniema Province, in the eastern part of the Democratic Republic of Congo.
Provincial statistics seen by IPS for the districts of Kibombo and Kindu, show that since mid-April, a measles epidemic has caused more than 15 deaths at health facilities, and three or four times as many have died at home, in cases where families did not take stricken children to medical centres.
"The villages further upstream along the Congo River are the worst affected by measles," says Dr Théo Katako, interim head of the Provincial Inspectorate of the Ministry of Public Health. "Meanwhile, the province was only able to organise a vaccination campaign against polio, for lack of resources to take on these two epidemics at once."

"The total number dying of measles at home in April, could have been more than 60; for lack of a way for these families to bring these patients to the hospital because of the distance to health facilities," says Germain Musombo, a member of civil society in Maniema.
"The fear is even greater because the measles vaccination campaign, planned for last week, did not take place for reasons no one has explained," says Julie Bibi Bin Kito, a small trader and mother of a six-year-old who died of measles last week. "We who don't have money would have benefited from these vaccinations to protect the lives of our children."
She told IPS it would take more than four hours to walk to the nearest hospital to her home. She has no access to a car, and that hospital requires patients to pay to open a medical file before they can receive care. Neither she nor her husband had any money on the evening their child died.
Dying of poverty
"The question of poverty is critical throughout the province of Maniema," says Musombo. "A large majority of the population lives on rice and cassava leaves grown in small gardens near the family home. There is also the fact that the province is landlocked and doesn't benefit from commerce with the rest of the country."
The province is generally underdeveloped, with few people enjoying access to clean drinking water and just 52,000 of the provinces' estimated population of two million having access to electricity.
"With the population living under these conditions, there is cause for concern," says Martin Bila Omari, who is responsible for epidemiology at the provincial inspectorate of the health ministry.
"The provincial authorities have outlined a plan to end the epidemic and prevent new cases," says Bila Omari, "which will cost 180,000 dollars. But there is an acute shortage of financial resources to carry it out. The modest provincial budget will not allow for an urgent response."
For the moment, the authorities are trying to raise awareness. "Several weeks ago, the government launched and awareness campaign for the population, and families in particular, on the necessity of vaccinations for children between six and 59 months and urging them to bring children in from time to time for their routine vaccinations," Dr Benoît Kebela Ilunga, director of the campaign against measles at the national health ministry, told IPS.
He said the government has also strengthened monitoring of new cases with a view to arresting the present outbreak of measles.
"Happily the province is benefiting from the support of UNICEF [the United Nations Children's Fund] and other international humanitarian organisations like Médecins Sans Frontières - France," says Bila Omari, adding that a measles vaccination campaign could be organised almost immediately as these partners already have the necessary vaccines in hand.
While the province of Maniema struggles with epidemics of measles and polio, non-governmental organisations warn of 80 cases of measles in the territory of Bukama, in Katanga province, in the southeast of the DRC. 


....................

Note: The viewpoint expressed in this article is solely that of the writer / news outlet. "FATA Awareness Initiative" Team may not agree with the opinion presented.
....................

We Hope You find the info useful. Keep visiting this blog and remember to leave your feedback / comments / suggestions / requests / corrections.
With Regards,
"FATA Awareness Initiative" Team.

Tuesday, May 17, 2011

CDC: New regimen shortens Tuberculosis (TB) treatment to three months (Associated Press, 16 May 2011)

Courtesy: "Associated Press (AP)", 16 May 2011
CDC: New regimen drastically shortens TB treatment

ATLANTA (AP) -- Health officials on Monday celebrated a faster treatment for people who have tuberculosis but aren't infectious, after investigators found a new combination of pills knocks out the disease in three months instead of nine.
That means more people are likely to finish their treatment for latent tuberculosis, Centers for Disease Control and Prevention officials said.
"New, simpler ways to prevent TB disease are urgently needed, and this breakthrough represents one of the biggest developments in TB treatment in decades," CDC Director Dr. Tom Frieden said, in a prepared statement.
For decades, people infected with TB bacteria but not ill have been treated with a special TB pill, isoniazid, taken once a day for nine months. It's been the standard regimen despite problems getting people to take the pill every day.

But in one of the largest federal trials to examine preventive tuberculosis therapy, investigators found that another regimen was just as effective. Just once a week and for just three months, patients took a larger dose of isoniazid and also a dose of another antibiotic, rifapentine.
About 82 percent of the people in the three-month regimen completed the full treatment, while just 69 percent on the nine-month regimen did. Rates of the most serious side effects were the same for both regimens.
What's more, only seven cases of TB disease developed in people on the new treatment, compared with 15 in the standard group.
"It was quite effective," said Dr. Wafaa El-Sadr, a Columbia University professor of medicine and epidemiology who was involved in the study.
The three-month regimen is also more expensive. The medicines alone cost about $160, most of that from the price of rifapentine. Nine months of isoniazid costs less than $6.
The costs of both regimens grow when lab tests and other aspects of care are thrown in, but the three-month regimen still ends up being more than twice as expensive as the standard treatment.
The study was led by Dr. Timothy Sterling of Vanderbilt University and was presented Monday at the American Thoracic Society International Conference in Denver.
The CDC is working with consultants to examine the study's results and draft new guidelines for treatment of latent TB. The guidelines should be finished later this year, agency officials said.
Tuberculosis is caused by bacteria spread from person to person through the air. TB usually affects the lungs, and can lead to symptoms such as chest pain and coughing up blood. Globally, it kills about 1.7 million people each year.
Thanks to antibiotics and other measures, the TB rate in the United States has been falling for years. Last year, it hit an all-time low - a total of 11,181 reported cases of TB illness.
But more than 11 million Americans have latent TB, meaning they are infected with the TB bacteria but have not had symptoms and are not infectious.
About 5 percent to 10 percent of people with latent TB develop the disease if not treated, meaning they are a major obstacle to eliminating TB in the United States.
"The 11 million persons with latent TB represent a ticking bomb. They're the source of future TB cases," said Dr. Kenneth Castro, director of the CDC's Division of Tuberculosis Elimination.
Most Americans with latent TB don't know they are infected, but testing has been targeted at groups of people who tend to have higher rates of TB infection or who are more susceptible to TB infection progressing into illness. About 300,000 to 400,000 Americans with latent TB start treatment each year.
But many don't stick with it, sometimes because they feel well and don't see the need to keep taking a pill against an illness they haven't developed. Some don't like that they cannot drink alcohol while taking isoniazid.
The study looked at about 8,000 people with latent TB in the United States, Canada, Brazil and Spain. They were followed for nearly three years from the time they started the study. Most of the top TB research centers in the United States were involved.
About half were given the standard treatment, a daily 300 milligrams dose of isoniazid for nine months, and they took it on their own. The other half were put on a 900-milligram dose of isoniazid and a 900 milligram dose of rifapentine, but did it in front of a doctor or other health-care worker.
The researchers acknowledged that follow-up studies are needed to see if patients on the three-month regimen are as faithful at taking their medicine when they aren't being monitored.
Also, it's not clear how well the strategy would work in countries where TB is more common and the odds of re-infection are much higher, health officials said

....................

Note: The viewpoint expressed in this article is solely that of the writer / news outlet. "FATA Awareness Initiative" Team may not agree with the opinion presented.
....................

We Hope You find the info useful. Keep visiting this blog and remember to leave your feedback / comments / suggestions / requests / corrections.
With Regards,
"FATA Awareness Initiative" Team.

Saturday, May 14, 2011

Experts debate destroying last smallpox viruses stored in US and Russia (Associated Press, 13 May 2011)

Courtesy: “Associated Press (AP)”, 13 May 2011
Experts debate destroying last smallpox viruses
MARIA CHENG
LONDON (AP) -- Smallpox, one of the world's deadliest diseases, eradicated three decades ago, is kept alive under tight security today in just two places - the United States and Russia.
Many other countries say the world would be safer if those stockpiles of the virus were destroyed.
Now for the fifth time, at a World Health Organization meeting next week, they will push again for the virus' destruction. And again it seems likely their efforts will be futile.
U.S. and Russian government officials say it is essential they keep some smallpox alive in case a future biological threat demands more tests with the virus. They also say the virus samples are still needed to develop experimental vaccines and drugs.
It was in 1996 that WHO's member countries first agreed smallpox should be destroyed. But they have repeatedly delayed a demand for destruction so that scientists could develop safer smallpox vaccines and drugs. That's now been done: There are two vaccines, a third in the works, and there are drugs for treating it, but not curing it.

Yet even if most of WHO's member countries vote to set a new date for destruction, the agency doesn't have the power to enforce the decision.
The scientific community remains divided over whether the smallpox samples should be destroyed. The respected journal Nature editorialized against it earlier this year, arguing that scientists need the ability to do further research, and perhaps develop new vaccines and treatments in an era of possible biological attack. However, one of the most prominent figures in wiping out the deadly, disfiguring disease is in favor of destroying all remnants of it.
"It would be an excellent idea to destroy the smallpox viruses," said Dr. Donald A. Henderson, who led WHO's eradication effort in the 1970s. "This is an organism to be greatly feared."
He says possession of smallpox by those not authorized to have it should be made a crime against humanity and that international authorities should prosecute any country found with it.
A report by independent researchers commissioned by WHO last year concluded there was no compelling scientific reason to hang onto the viruses. Yet other scientists contend the stockpiles could still provide valuable information in the future.
Smallpox is one of the most lethal diseases in history. For centuries, it killed about one-third of the people it infected, including Queen Mary II of England, and left most survivors with deep scars on their faces from the hideous pus-filled lesions. The last known case was in Britain in 1978 when a university photographer who worked above a lab handling smallpox died after being accidentally exposed to it from the building's air duct system.
Smallpox vaccines are made from vaccinia, a milder related virus. "We have many ways of looking at smallpox, including gene mapping, that means we don't need the actual (smallpox) virus," said Henderson, who is now with the Center for Biosecurity at the University of Pittsburgh Medical Center.
American and Russian officials disagree.
Dr. Nils Daulaire, director of the U.S. Department of Health and Human Services' Office of Global Affairs, said the U.S. will again ask WHO to postpone a decision calling for the stockpile's destruction. He said U.S. scientists need more time to finish research into how well new vaccines and drugs work against the virus. But he acknowledged U.S. officials also want their own supply in case terrorists unleash smallpox as a biological weapon and additional study is needed.
A scientist at the Russian laboratory where smallpox is kept, who spoke anonymously because he was not authorized to speak to the press, said the virus should be kept in case similar ones pop up in the future and more studies are needed.
Meanwhile, officials from developing countries are anxious to close the last chapter on the disease.
"There is a consensus to destroy the viruses, so how come we're in this situation where we're pandering to the U.S. and Russia?" asked Lim Li Ching, a biosafety expert at Third World Network, a group that lobbies on behalf of developing countries.
Oyewale Tomori, a virology professor at Redeemer's University in Nigeria, said most African countries want smallpox destroyed. Tomori also sits on a WHO Advisory Committee on smallpox. "Africa is one part of the world where a biological attack with smallpox is likely to have a more devastating effect," he said.
Keiji Fukuda, WHO's assistant director-general for health security and the environment, said the agency remains concerned about the possibility of smallpox's return. "The chance of an outbreak is reasonably low, but not zero," he said. With the new vaccines and drugs, Fukuda was optimistic any smallpox outbreak would be stamped out relatively quickly though acknowledged any new cases might spark global alarm.
"If smallpox were to reappear, we would be in a much better situation than in the past, considering the vaccine supplies and strategies that have been demonstrated to work," he said. He guessed that stamping out a smallpox outbreak would be faster than the four months it took to mostly end the 2003 global outbreak of SARS, where doctors could only isolate patients and trace suspect cases. With smallpox, Fukuda said countries could quickly vaccinate people in surrounding areas and that drugs could be sent to treat patients.
Fukuda said many rich countries like the U.S. have their own smallpox vaccine stockpiles. WHO also has at least 30 million doses for poor countries in case the virus re-emerges, but that supply uses older vaccines that can trigger AIDS in people who have HIV.
David Evans, a smallpox expert at the University of Alberta, who was part of the WHO team that inspected the U.S. and Russian labs holding smallpox several years ago, says he doubts the virus could escape from either facility. The viruses are kept at the U.S. Centers for Disease Control and Prevention in Atlanta and the State Research Center of Virology and Biotechnology in Novosibirsk, Siberia.
Laboratories where smallpox is kept have the highest possible containment measures. Scientists who work with the virus use fingerprint or retinal scans to get inside, wear a full-body suit including gloves and goggles, and shower with strong disinfectant before leaving the lab and taking off the suit. The U.S. smallpox viruses, which include samples from Britain, Japan and the Netherlands, are stored in liquid nitrogen.
Rumors about stockpiles in countries like Iraq and North Korea have never been proven, and Evans said it would be too difficult to experiment with smallpox and keep it a secret. "The nations I would worry about, weird places run by odd dictators, they're just not capable of doing this stuff," he said.
Evans thinks it's unlikely terrorists would resort to smallpox in a biological attack. "If you want to disrupt countries, there are lots of easier ways to do it than to experiment with something so dangerous," he said.
---
AP Medical Writer Mike Stobbe in Atlanta and Associated Press Writer Mansur Mirovalev in Moscow contributed to this report.
....................

Note: The viewpoint expressed in this article is solely that of the writer / news outlet. "FATA Awareness Initiative" Team may not agree with the opinion presented.
....................

We Hope You find the info useful. Keep visiting this blog and remember to leave your feedback / comments / suggestions / requests / corrections.
With Regards,
"FATA Awareness Initiative" Team.

Earlier HIV therapy protects against virus spread (Associated Press, 12 My 2011)


Courtesy: “Associated Press (AP)”, 12 May 2011
Earlier HIV therapy protects against virus spread
LAURAN NEERGAARD
WASHINGTON (AP) -- Treating HIV right away, before patients are too sick, dramatically lowers their chances of spreading the AIDS virus to a sexual partner, says a major international study that may convince more doctors to offer medication sooner.
The nine-nation study offers convincing evidence of what scientists have long believed - that HIV medicines don't just benefit the patient, but may act as a preventive by making those people less infectious. Earlier treatment in the study meant patients were 96 percent less likely to spread the virus to their uninfected partners, according to preliminary results announced Thursday by the National Institutes of Health, which oversaw the research.
Those findings were striking enough that the NIH said it was stopping the study four years ahead of schedule to get the word out.

When HIV patients should start taking antiviral drugs is an important question. The pills are lifesaving but also expensive - up to $15,000 a year in the U.S. - and carry a range of side effects from diarrhea to liver damage.
NIH's Dr. Anthony Fauci said the new study promises to change practice worldwide. In developing countries, where the drugs cost a few hundred dollars a year, patients tend to be far sicker before getting medication. Even in the U.S., where therapy starts sooner, doctors don't always treat as early as was done in this study.
"It has less to do with a decision about what's good for you from a personal health standpoint than what is the extra added benefit from starting earlier, i.e., transmission, especially if you have a partner who's uninfected," said Fauci, director of the National Institute of Allergy and Infectious Diseases.
Condoms remain crucial for protection - the medications don't change that longtime recommendation. All 1,763 couples in the study, where one partner had HIV and the other didn't, were urged to use them.
"HIV-positive people cannot assume they are not infectious simply because they are already on treatment medications," warned Dr. Thomas Frieden, director of the Centers for Disease Control and Prevention.
Previous research has suggested that HIV patients who use the medications are less likely to spread infection. But the $73 million study announced Thursday is the first to rigorously test that.
The couples, most of whom were heterosexual, were randomly divided. Among half, the HIV-infected partner started medication immediately after diagnosis. Among the other half, the infected partner delayed using the drugs until his or her level of CD4 cells - a way to measure the strength of the immune system - dropped below 250 or symptoms appeared.
In 28 couples, the uninfected person became infected by their partner. Only one of those infections occurred among the couples where the infected person was treated early, Fauci said.
The other 27 cases in which HIV spread involved couples that delayed drug treatment.
Importantly, more than half of those infections occurred when the patient's CD4 count remained greater than 350, Fauci noted. That number indicates only moderate immune damage. Most developing countries don't offer treatment until CD4 levels dip lower than that.
U.S. guidelines recently were changed to recommend that treatment begin when that immune system number is below 500, although many doctors haven't yet begun following that advice, said Dr. Michael Horberg of the HIV Medicine Association and HIV/AIDS director for Kaiser Permanente. Some experts would treat even sooner.
The earlier treatment also helped reduce some complications - such as a form of tuberculosis - in the original patients, but there was no significant difference in deaths between the two groups.
The study included couples from Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, Zimbabwe, as well as a few from the United States.
---
NIH: http://www.niaid.nih.gov
....................

Note: The viewpoint expressed in this article is solely that of the writer / news outlet. "FATA Awareness Initiative" Team may not agree with the opinion presented.
....................

We Hope You find the info useful. Keep visiting this blog and remember to leave your feedback / comments / suggestions / requests / corrections.
With Regards,
"FATA Awareness Initiative" Team.